
Revenue from operations for the second quarter of FY22 stood at Rs 380.13 crore as against Rs 340.32 crore in the year-ago period. The e-commerce and international business verticals contributed to around 7%and 5%, respectively, of the total net sales, it added.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3CrOLau
via
IFTTT
0 comments:
Post a Comment